| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |